Chair in Translational Cancer Genomics, Queen's University Belfast

Mark Lawler is a professor in the School of Medicine, Dentistry and Biomedical Sciences and the Centre for Cancer Research and Cell Biology.

He has over 20 years experience in cancer research with a significant record of research achievement, having published over 130 peer-reviewed publications and received numerous national and international awards.

He is an experienced contributor to national/international science policy development as chair/member of committees in biomedical science, biotechnology, cancer research, scholar exchange, bioethics, biobanking, cancer care.

He is a member of the Ethics Review Expert Group DG Research and Innovation, European Commission (EC) and Independent Expert/Evaluator for EC, Health Directorate (Bioethics).

He is also a passionate advocate for the development of outreach activities, fostering increased public understanding of science/medicine.

Specialties: Genetics, Molecular/Experimental Medicine, Cancer biology/medicine, Drug discovery, Graduate education, Bioethics, Science/education policy, Art Therapy, Public perception of Science.

Experience

  • –present
    Chair in Translational Cancer Genomics, Queen's University Belfast